These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15684603)

  • 21. Protein expression of bax, bcl-2, and p53 in patients with non-Hodgkin's gastric lymphoma: prognostic significance.
    Charalambous GK; Gomatos IP; Konstadoulakis MM; Messaris EG; Manouras AJ; Apostolou AE; Leandros EA; Karayannis MK; Androulakis GA
    World J Surg; 2000 May; 24(5):608-14. PubMed ID: 10787085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High bad and bcl-xL gene expression and combined bad, bcl-xL, bax and bcl-2 mRNA levels: molecular predictors for survival of stage 2 soft tissue sarcoma patients.
    Köhler T; Würl P; Meye A; Lautenschläger C; Bartel F; Borchert S; Bache M; Schmidt H; Holzhausen HJ; Taubert H
    Anticancer Res; 2002; 22(3):1553-9. PubMed ID: 12168836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the expression of P glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat shock protein 27 on response to induction therapy and long-term survival in patients with de novo acute myeloid leukemia.
    Kasimir-Bauer S; Beelen D; Flasshove M; Noppeney R; Seeber S; Scheulen ME
    Exp Hematol; 2002 Nov; 30(11):1302-8. PubMed ID: 12423683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's lymphomas.
    Kanavaros P; Stefanaki K; Vlachonikolis J; Eliopoulos G; Kakolyris S; Rontogianni D; Gorgoulis V; Georgoulias V
    Histol Histopathol; 2000 Apr; 15(2):445-53. PubMed ID: 10809363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of p53 and Bcl-2 in acute lymphoblastic leukemia.
    Sahu GR; Das BR
    Oncol Rep; 2002; 9(6):1391-8. PubMed ID: 12375054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of p53 mutations, bax, and spontaneous apoptosis in maxillary sinus squamous cell carcinoma.
    Bandoh N; Hayashi T; Kishibe K; Takahara M; Imada M; Nonaka S; Harabuchi Y
    Cancer; 2002 Apr; 94(7):1968-80. PubMed ID: 11932899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor suppressor gene alteration in adult acute lymphoblastic leukemia (ALL). Analysis of retinoblastoma (Rb) and p53 gene expression in lymphoblasts of patients with de novo, relapsed, or refractory ALL treated in Southwest Oncology Group studies.
    Tsai T; Davalath S; Rankin C; Radich JP; Head D; Appelbaum FR; Boldt DH
    Leukemia; 1996 Dec; 10(12):1901-10. PubMed ID: 8946929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells.
    Huang Y; Ibrado AM; Reed JC; Bullock G; Ray S; Tang C; Bhalla K
    Leukemia; 1997 Feb; 11(2):253-7. PubMed ID: 9009089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and prognostic significance of the apoptotic genes BCL2L13, Livin, and CASP8AP2 in childhood acute lymphoblastic leukemia.
    Yang YL; Lin SR; Chen JS; Lin SW; Yu SL; Chen HY; Yen CT; Lin CY; Lin JF; Lin KH; Jou ST; Hu CY; Chang SK; Lu MY; Chang HH; Chang WH; Lin KS; Lin DT
    Leuk Res; 2010 Jan; 34(1):18-23. PubMed ID: 20109966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association of Bcl-xL and p53 expression with survival outcomes in oropharyngeal cancer.
    Ziai H; Alenazi A; Hearn M; O'Connell DA; Puttagunta L; Barber B; Harris JR; Seikaly H; Biron VL
    Cancer Biomark; 2019; 24(2):141-151. PubMed ID: 30614804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of Bcl-2, Bcl-XL and p53 in colorectal cancer.
    Han HS; Park YM; Hwang TS
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1108-14. PubMed ID: 16824061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of P53 and bcl-2 proteins in T-cell lymphoblastic lymphoma: prognostic implications.
    Naresh KN; Banavali SD; Bhatia KG; Magrath I; Soman CS; Advani SH
    Leuk Lymphoma; 2002 Feb; 43(2):333-7. PubMed ID: 11999565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of immunohistochemical expression of p53, bax, Bcl-2 and Bcl-xL in resected non-small-cell lung cancers.
    Groeger AM; Esposito V; De Luca A; Cassandro R; Tonini G; Ambrogi V; Baldi F; Goldfarb R; Mineo TC; Baldi A; Wolner E
    Histopathology; 2004 Jan; 44(1):54-63. PubMed ID: 14717670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Expressions of P53, Bcl-2, and P-Glycoprotein and Prognostic Impact in Patients with Peripheral T-Cell Lymphoma (PTCL).
    Julamanee J; Kayasut K; Lekhakula A
    J Med Assoc Thai; 2015 Oct; 98(10):950-6. PubMed ID: 26638586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bax is an important determinant of chemosensitivity in pediatric tumor cell lines independent of Bcl-2 expression and p53 status.
    McPake CR; Tillman DM; Poquette CA; George EO; Houghton JA; Harris LC
    Oncol Res; 1998; 10(5):235-44. PubMed ID: 9802058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency and prognostic significance of murine double minute protein-2 overexpression and p53 gene mutations in childhood acute lymphoblastic leukemia.
    Hendy OM; Elghannam DM; El-Sharnouby JA; Goda EF; El-Ashry R; Al-Tonbary Y
    Hematology; 2009 Dec; 14(6):335-40. PubMed ID: 19941740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute leukemias.
    Wojcik I; Szybka M; Golanska E; Rieske P; Blonski JZ; Robak T; Bartkowiak J
    Neoplasma; 2005; 52(4):318-24. PubMed ID: 16059649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity.
    Hayward RL; Macpherson JS; Cummings J; Monia BP; Smyth JF; Jodrell DI
    Clin Cancer Res; 2003 Jul; 9(7):2856-65. PubMed ID: 12855666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.
    Apolinario RM; van der Valk P; de Jong JS; Deville W; van Ark-Otte J; Dingemans AM; van Mourik JC; Postmus PE; Pinedo HM; Giaccone G
    J Clin Oncol; 1997 Jun; 15(6):2456-66. PubMed ID: 9196162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX.
    Nehls O; Okech T; Hsieh CJ; Enzinger T; Sarbia M; Borchard F; Gruenagel HH; Gaco V; Hass HG; Arkenau HT; Hartmann JT; Porschen R; Gregor M; Klump B
    Br J Cancer; 2007 May; 96(9):1409-18. PubMed ID: 17426704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.